Target- |
MechanismChelating agents |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
MechanismChelating agents |
|
|
|
|
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Fe Pharmaceuticals (Canada), Inc.
0 Patents (Medical) associated with Fe Pharmaceuticals (Canada), Inc.
100 Deals associated with Fe Pharmaceuticals (Canada), Inc.
100 Translational Medicine associated with Fe Pharmaceuticals (Canada), Inc.